Pietro Locantore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pietro Locantore has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Rosa Maria Paragliola
Departmental Faculty of Medicine, UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy
10 shared publications Alfredo Pontecorvi
Division of Endocrinology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
8 shared publications- Andrea Corsello
Unità di Chirurgia Endocrina, Ospedale Isola Tiberina – Gemelli Isola, Rome, 00186, Italy | Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, 00168, Italy
8 shared publications - Alfredo Pontecorvi
Dipartimento di Medicina e chirurgia traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy
6 shared publications Andrea Corsello
U.O.C. di Endocrinologia e Diabete, Fondazione Policlinico Gemelli – IRCCS, Università Cattolica del Sacro Cuore, Roma, Italia
5 shared publications- Gianluca Cera
Unit of Endocrinology, Department of Translational Medicine and Surgery Fondazione Policlinico “A. Gemelli” IRCCS Università Cattolica del Sacro Cuore Rome Italy
5 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 117 (1)
Congenital syphilis as a failure of the maternal–fetal prevention cascade: Clinical implications for pregnant migrant and structurally vulnerable women in high-income settings — an ESCMID study group for infections in Travellers and migrants (ESGITM) perspective
- 30 September 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 117 (1)
Open AccessCongenital syphilis as a failure of the maternal–fetal prevention cascade: Clinical implications for pregnant migrant and structurally vulnerable women in high-income settings — an ESCMID study group for infections in Travellers and migrants (ESGITM) perspective
- Open Access
- 2 January 2026
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 92 (1) , 88
Implementation and Access Gaps in Infectious Disease Screening for Migrants in Europe: A Structured Review with Thematic Synthesis From the ESGITM Group
Background: Infectious disease screening is widely recommended for migrants in Europe, yet implementation remains inconsistent across countries and settings. While guidance has focused on which infections to screen for, less attention has been paid to how screening is delivered, accessed, and linked to care. This structured review with thematic synthesis aimed to synthesize evidence on implementation gaps, barriers, and facilitators, with particular attention to differences across the migratory cycle. Methods: A structured search was conducted across PubMed, Scopus, Web of Science, and Google Scholar for publications from January 2000 to February 2026, addressing infectious disease screening or related migrant health assessments in European settings. Of 49 included publications, 13 empirical studies formed the primary analytical basis and were quality‑appraised using the Mixed Methods Appraisal Tool (MMAT, 2018); the remaining 36 contextualizing publications were used to interpret findings. Eligibility screening was performed independently by two reviewers. Results: Six interconnected thematic domains shaped screening implementation: administrative and legal barriers; communication, language, and cultural mediation; trust, stigma, and perceived coercion; organizational capacity and fragmented care pathways; the role of NGOs and community actors; and contextual differences across the migratory cycle. Barriers varied across the screening‑to‑care cascade: communication barriers and mistrust primarily affected uptake; legal and organizational barriers constrained linkage to diagnosis and treatment; and legal instability and fragmented services undermined continuity of care. First‑arrival settings were characterized by systematic screening and high service pressure; long‑term settlement contexts relied more heavily on primary care capacity, trust, and legal entitlement. Conclusions: Implementation gaps are driven less by the absence of clinical guidance than by structural, organizational, and relational barriers limiting access, linkage, and continuity. Screening should be embedded within integrated, migrant‑centered care pathways supported by cultural mediation, trusted community actors, and separation from immigration enforcement.
- 2 January 2026
- Published by Ubiquity Press, Ltd. in Annals of Global Health
- Vol. 92 (1) , 88
Open AccessImplementation and Access Gaps in Infectious Disease Screening for Migrants in Europe: A Structured Review with Thematic Synthesis From the ESGITM Group
Background: Infectious disease screening is widely recommended for migrants in Europe, yet implementation remains inconsistent across countries and settings. While guidance has focused on which infections to screen for, less attention has been paid to how screening is delivered, accessed, and linked to care. This structured review with thematic synthesis aimed to synthesize evidence on implementation gaps, barriers, and facilitators, with particular attention to differences across the migratory cycle. Methods: A structured search was conducted across PubMed, Scopus, Web of Science, and Google Scholar for publications from January 2000 to February 2026, addressing infectious disease screening or related migrant health assessments in European settings. Of 49 included publications, 13 empirical studies formed the primary analytical basis and were quality‑appraised using the Mixed Methods Appraisal Tool (MMAT, 2018); the remaining 36 contextualizing publications were used to interpret findings. Eligibility screening was performed independently by two reviewers. Results: Six interconnected thematic domains shaped screening implementation: administrative and legal barriers; communication, language, and cultural mediation; trust, stigma, and perceived coercion; organizational capacity and fragmented care pathways; the role of NGOs and community actors; and contextual differences across the migratory cycle. Barriers varied across the screening‑to‑care cascade: communication barriers and mistrust primarily affected uptake; legal and organizational barriers constrained linkage to diagnosis and treatment; and legal instability and fragmented services undermined continuity of care. First‑arrival settings were characterized by systematic screening and high service pressure; long‑term settlement contexts relied more heavily on primary care capacity, trust, and legal entitlement. Conclusions: Implementation gaps are driven less by the absence of clinical guidance than by structural, organizational, and relational barriers limiting access, linkage, and continuity. Screening should be embedded within integrated, migrant‑centered care pathways supported by cultural mediation, trusted community actors, and separation from immigration enforcement.
- Top Cited PapersOpen Access
- 6 August 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (2) , 253-263
Antimicrobial Resistance in Sub-Saharan Africa: A Comprehensive Landscape Review
: Antimicrobial resistance (AMR) is a critical health challenge in sub-Saharan Africa (SSA), driven by socioeconomic disparities, weak healthcare systems, and inadequate pharmaceutical regulation. This review examines AMR prevalence, drivers, and consequences in SSA, emphasizing the need for urgent interventions. A literature review was conducted using PubMed, Web of Science, Scopus, and Google Scholar, including studies published from January 2000 to June 2024. The focus was on AMR epidemiology, public health impacts, and interventions specific to SSA. High resistance rates were identified in Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. Key drivers include limited healthcare access; antibiotic misuse; poor surveillance; inadequate water, sanitation, and hygiene infrastructure; and poverty. AMR leads to increased mortality, prolonged hospital stays, and higher healthcare costs, with SSA projected to face 4.1 million AMR-related deaths annually by 2050 without action. Addressing AMR in SSA requires strengthening healthcare systems, expanding surveillance, enforcing pharmaceutical regulations, and enhancing education. International collaboration and funding are essential to mitigate AMR’s impacts and support progress toward universal health coverage and the Sustainable Development Goals.
- 6 August 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 113 (2) , 253-263
Top Cited PapersOpen AccessAntimicrobial Resistance in Sub-Saharan Africa: A Comprehensive Landscape Review
: Antimicrobial resistance (AMR) is a critical health challenge in sub-Saharan Africa (SSA), driven by socioeconomic disparities, weak healthcare systems, and inadequate pharmaceutical regulation. This review examines AMR prevalence, drivers, and consequences in SSA, emphasizing the need for urgent interventions. A literature review was conducted using PubMed, Web of Science, Scopus, and Google Scholar, including studies published from January 2000 to June 2024. The focus was on AMR epidemiology, public health impacts, and interventions specific to SSA. High resistance rates were identified in Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. Key drivers include limited healthcare access; antibiotic misuse; poor surveillance; inadequate water, sanitation, and hygiene infrastructure; and poverty. AMR leads to increased mortality, prolonged hospital stays, and higher healthcare costs, with SSA projected to face 4.1 million AMR-related deaths annually by 2050 without action. Addressing AMR in SSA requires strengthening healthcare systems, expanding surveillance, enforcing pharmaceutical regulations, and enhancing education. International collaboration and funding are essential to mitigate AMR’s impacts and support progress toward universal health coverage and the Sustainable Development Goals.
- Open Access
- 23 July 2025
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 48 (10) , 2295-2313
Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy
Aim: The present guideline (GL) is aimed to improve and standardize the treatment of primary hypothyroidism in non-pregnant adults and to offer all the patients the best possible care across the Italian country. Target population: Non-pregnant adults with hypothyroidism. Excluded population: This GL does not cover the treatment of hypothyroidism in children and adolescents under 18 years of age, in women who are pregnant or breastfeeding, nor in subjects with central hypothyroidism. Also patients who require suppressive therapy with levothyroxine after thyroidectomy for thyroid cancer and those with transient iatrogenic hypothyroidism were not considered in this GL. Methods: The direct costs and the utilization of resources over time were evaluated for the implementation of the appropriate management within the National Health Service. Recommendations were based on the analysis, according to the GRADE methodology, of the evidence from literature. Patients preferences were collected and verified by means of specific bibliographic research and the active participation of two patients’ representatives in the GL development group. Results: The present GL provides 4 formal graded recommendations and 16 ungraded indications for good clinical practice. An elevated agreement was consistently obtained among the panel members. Conclusions: The present GL provides operative recommendations—based on the best available evidence and cost-effectiveness analysis—for the treatment of adult patients with primary hypothyroidism. The expected benefits from the dissemination, application and implementation of this GL are the improvement of the quality of care, its homogenization across the national territory and the rationalization of health expenditure in the respect of patient preferences.
- 23 July 2025
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 48 (10) , 2295-2313
Open AccessItalian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy
Aim: The present guideline (GL) is aimed to improve and standardize the treatment of primary hypothyroidism in non-pregnant adults and to offer all the patients the best possible care across the Italian country. Target population: Non-pregnant adults with hypothyroidism. Excluded population: This GL does not cover the treatment of hypothyroidism in children and adolescents under 18 years of age, in women who are pregnant or breastfeeding, nor in subjects with central hypothyroidism. Also patients who require suppressive therapy with levothyroxine after thyroidectomy for thyroid cancer and those with transient iatrogenic hypothyroidism were not considered in this GL. Methods: The direct costs and the utilization of resources over time were evaluated for the implementation of the appropriate management within the National Health Service. Recommendations were based on the analysis, according to the GRADE methodology, of the evidence from literature. Patients preferences were collected and verified by means of specific bibliographic research and the active participation of two patients’ representatives in the GL development group. Results: The present GL provides 4 formal graded recommendations and 16 ungraded indications for good clinical practice. An elevated agreement was consistently obtained among the panel members. Conclusions: The present GL provides operative recommendations—based on the best available evidence and cost-effectiveness analysis—for the treatment of adult patients with primary hypothyroidism. The expected benefits from the dissemination, application and implementation of this GL are the improvement of the quality of care, its homogenization across the national territory and the rationalization of health expenditure in the respect of patient preferences.
- Open Access
- 29 April 2025
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 7 (3) , dlaf081
Knowledge, practices, educational needs and hospital engagement in Infection Prevention and Control (IPC) among Italian healthcare workers and students: results from a national multicentre survey
Objective: This study assesses the knowledge, practices, educational needs and hospital engagement in IPC among healthcare workers (HCWs) and students in Italy. Methods: A national cross-sectional observational study was conducted from April to July 2024. Participants completed a validated questionnaire based on WHO and CDC guidelines. Four outcomes were evaluated: (i) knowledge of IPC, (ii) self-reported compliance, (iii) satisfaction with education and (iv) hospital engagement in IPC. Results: Among respondents (n = 1063, 67.75% female) significant gaps in IPC knowledge were noted, with only 66.1% correctly identifying key hand hygiene moments. Compliance was low, with only 43.3% always adhering to hand hygiene rules. Satisfaction with IPC education was also low (28%). While alcohol-based hand gel was widely available (84.2%), only 36.6% received formal hand hygiene training before onboarding. Multivariate analysis revealed that female HCWs had higher IPC knowledge [adjusted odds ratio (aOR) 1.55, 95% CI: 1.04–2.31] and better compliance (aOR 1.72, 95% CI: 1.01–2.92). Younger HCWs demonstrated greater knowledge and satisfaction. Surgical ward staff, despite greater education satisfaction, exhibited lower IPC knowledge (aOR 0.53, 95% CI: 0.32–0.87). Nurses and health assistants received more hospital IPC training (aOR 1.59, 95% CI: 1.04–2.46; aOR 5.83, 95% CI: 1.94–18.89, respectively). Finally, the presence of a hospital IPC team positively correlated with all outcomes, including higher IPC knowledge (aOR 2.68, 95% CI: 1.79–4.05) and adherence (aOR 3.4, 95% CI: 1.92–6.3). Conclusion: The study reveals substantial gaps in IPC knowledge, practices and education among Italian HCWs, emphasizing the urgent need for effective targeted interventions that require robust institutional support.
- 29 April 2025
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 7 (3) , dlaf081
Open AccessKnowledge, practices, educational needs and hospital engagement in Infection Prevention and Control (IPC) among Italian healthcare workers and students: results from a national multicentre survey
Objective: This study assesses the knowledge, practices, educational needs and hospital engagement in IPC among healthcare workers (HCWs) and students in Italy. Methods: A national cross-sectional observational study was conducted from April to July 2024. Participants completed a validated questionnaire based on WHO and CDC guidelines. Four outcomes were evaluated: (i) knowledge of IPC, (ii) self-reported compliance, (iii) satisfaction with education and (iv) hospital engagement in IPC. Results: Among respondents (n = 1063, 67.75% female) significant gaps in IPC knowledge were noted, with only 66.1% correctly identifying key hand hygiene moments. Compliance was low, with only 43.3% always adhering to hand hygiene rules. Satisfaction with IPC education was also low (28%). While alcohol-based hand gel was widely available (84.2%), only 36.6% received formal hand hygiene training before onboarding. Multivariate analysis revealed that female HCWs had higher IPC knowledge [adjusted odds ratio (aOR) 1.55, 95% CI: 1.04–2.31] and better compliance (aOR 1.72, 95% CI: 1.01–2.92). Younger HCWs demonstrated greater knowledge and satisfaction. Surgical ward staff, despite greater education satisfaction, exhibited lower IPC knowledge (aOR 0.53, 95% CI: 0.32–0.87). Nurses and health assistants received more hospital IPC training (aOR 1.59, 95% CI: 1.04–2.46; aOR 5.83, 95% CI: 1.94–18.89, respectively). Finally, the presence of a hospital IPC team positively correlated with all outcomes, including higher IPC knowledge (aOR 2.68, 95% CI: 1.79–4.05) and adherence (aOR 3.4, 95% CI: 1.92–6.3). Conclusion: The study reveals substantial gaps in IPC knowledge, practices and education among Italian HCWs, emphasizing the urgent need for effective targeted interventions that require robust institutional support.
- Open Access
- 28 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9)
Biochemical and Ultrasonographic Parameters Predicting Long-Term Hypothyroidism After Subacute Thyroiditis
Subacute thyroiditis (SAT) represents an inflammatory disease of the thyroid gland, often resulting from viral infections or post-viral inflammatory responses. Long-term hypothyroidism is a possible evolution, requiring frequent follow-up and, if necessary, levothyroxine (LT4) replacement therapy. We retrospectively included 139 patients (out of 428) with SAT referring to the “Fondazione Policlinico Universitario A. Gemelli IRCCS” (Rome), between 2010 and 2022 to identify predictive parameters for long-term hypothyroidism. We evaluated TSH, FT4, and FT3 at four timepoints (diagnosis, 4–8 weeks, 10–20 weeks, and 28–54 weeks). We started LT4 therapy in patients with TSH > 10 μUI/mL or between 4–10 μUI/mL, with symptoms of hypothyroidism. “Long-term hypothyroidism” was defined as TSH > 4 μUI/mL after LT4 reduction and/or withdrawal. Univariate analysis showed correlations between long-term hypothyroidism and higher FT3 and FT4 and positive anti-Tg Abs at diagnosis and higher changes in TSH values (ΔTSH), decreased thyroid volume, and persistence of hypoechoic areas during follow-up. Furthermore, more severe thyrotoxicosis at presentation may be associated with a faster progression to hypothyroidism, likely due to greater thyroid damage. Multivariable analysis found ΔTSH (TP2-TP1) as an independent predictor of hypothyroidism. We propose specific biochemical and ultrasonographic parameters at diagnosis and during follow-up as possible predictors of long-term hypothyroidism after SAT, reducing treatment and healthcare costs for most patients who will never require replacement therapy.
- 28 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9)
Open AccessBiochemical and Ultrasonographic Parameters Predicting Long-Term Hypothyroidism After Subacute Thyroiditis
Subacute thyroiditis (SAT) represents an inflammatory disease of the thyroid gland, often resulting from viral infections or post-viral inflammatory responses. Long-term hypothyroidism is a possible evolution, requiring frequent follow-up and, if necessary, levothyroxine (LT4) replacement therapy. We retrospectively included 139 patients (out of 428) with SAT referring to the “Fondazione Policlinico Universitario A. Gemelli IRCCS” (Rome), between 2010 and 2022 to identify predictive parameters for long-term hypothyroidism. We evaluated TSH, FT4, and FT3 at four timepoints (diagnosis, 4–8 weeks, 10–20 weeks, and 28–54 weeks). We started LT4 therapy in patients with TSH > 10 μUI/mL or between 4–10 μUI/mL, with symptoms of hypothyroidism. “Long-term hypothyroidism” was defined as TSH > 4 μUI/mL after LT4 reduction and/or withdrawal. Univariate analysis showed correlations between long-term hypothyroidism and higher FT3 and FT4 and positive anti-Tg Abs at diagnosis and higher changes in TSH values (ΔTSH), decreased thyroid volume, and persistence of hypoechoic areas during follow-up. Furthermore, more severe thyrotoxicosis at presentation may be associated with a faster progression to hypothyroidism, likely due to greater thyroid damage. Multivariable analysis found ΔTSH (TP2-TP1) as an independent predictor of hypothyroidism. We propose specific biochemical and ultrasonographic parameters at diagnosis and during follow-up as possible predictors of long-term hypothyroidism after SAT, reducing treatment and healthcare costs for most patients who will never require replacement therapy.
- Top Cited PapersOpen Access
- 17 January 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (1) , 197
Chronic Endometritis and Antimicrobial Resistance: Towards a Multidrug-Resistant Endometritis? An Expert Opinion
Chronic endometritis (CE) is a persistent inflammatory condition of the endometrium characterized by abnormal infiltration of plasma cells into the endometrial stroma. Frequently associated with repeated implantation failure, recurrent pregnancy loss, and infertility, CE significantly impacts women’s health, contributing to conditions such as abnormal uterine bleeding and endometriosis. Treatment typically involves antibiotic therapy; however, the efficacy of these treatments is increasingly compromised by the rise of antimicrobial resistance (AMR). This paper examines the critical links between AMR and CE, proposing strategies to enhance clinical management and optimize treatment outcomes.
- 17 January 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (1) , 197
Top Cited PapersOpen AccessChronic Endometritis and Antimicrobial Resistance: Towards a Multidrug-Resistant Endometritis? An Expert Opinion
Chronic endometritis (CE) is a persistent inflammatory condition of the endometrium characterized by abnormal infiltration of plasma cells into the endometrial stroma. Frequently associated with repeated implantation failure, recurrent pregnancy loss, and infertility, CE significantly impacts women’s health, contributing to conditions such as abnormal uterine bleeding and endometriosis. Treatment typically involves antibiotic therapy; however, the efficacy of these treatments is increasingly compromised by the rise of antimicrobial resistance (AMR). This paper examines the critical links between AMR and CE, proposing strategies to enhance clinical management and optimize treatment outcomes.
- Open Access
Hypercalcemia Following Adrenalectomy for Cushing Syndrome in a Patient with Post-Surgical Hypoparathyroidism
Background: Hypercalcemia is a frequently encountered laboratory finding in endocrinology, warranting accurate clinical and laboratory evaluation to identify its cause. While primary hyperparathyroidism and malignancies represent the most common causes, many other etiologies have been described, including some reports of hypercalcemia secondary to adrenal insufficiency. On the contrary, hypoparathyroidism is a relatively common cause of hypocalcemia, often arising as a complication of thyroid surgery. In real-world clinical practice, however, many challenges come into play, and a comprehensive approach may not be enough to establish a diagnosis. Case presentation: we describe a peculiar case of severe hypercalcemia occurring in a 47-year-old woman with a previous history of post-surgical permanent hypoparathyroidism treated with calcitriol (0.5 µg bid) and calcium carbonate (1 g qd), which persisted after withdrawal of these drugs. During her follow-up, an ACTH-independent Cushing syndrome was diagnosed, leading to a unilateral right adrenalectomy. In the two months following surgery, she was admitted to the emergency ward on three occasions because of severe, persistent, idiopathic hypercalcemia. On each occasion, parathyroid hormone levels were confirmed to be undetectable, with low vitamin D levels. Common and rare causes of hypercalcemia were excluded, and the persistence of severely elevated calcium levels led to the empirical use of intravenous clodronate, achieving remission of both hypercalcemia and, unexpectedly, hypoparathyroidism. After 8 months, due to borderline-reduced calcium, calcitriol at 0.5 µg qd was restarted. After 18 months of follow-up, the patient is well and normocalcemic, with low-dose calcitriol. Notably, the patient had no acute adrenal insufficiency, distinguishing this case from other post-adrenalectomy hypercalcemia reports. Conclusions: the history of hypoparathyroidism makes this case even more unusual, and it encourages careful follow-up of hypoparathyroid patients with Cushing syndrome. Ongoing observation, as well as new research on the physiopathology of cortisol and calcium metabolism, are needed to clarify the pathogenesis of this case.
Open AccessHypercalcemia Following Adrenalectomy for Cushing Syndrome in a Patient with Post-Surgical Hypoparathyroidism
Background: Hypercalcemia is a frequently encountered laboratory finding in endocrinology, warranting accurate clinical and laboratory evaluation to identify its cause. While primary hyperparathyroidism and malignancies represent the most common causes, many other etiologies have been described, including some reports of hypercalcemia secondary to adrenal insufficiency. On the contrary, hypoparathyroidism is a relatively common cause of hypocalcemia, often arising as a complication of thyroid surgery. In real-world clinical practice, however, many challenges come into play, and a comprehensive approach may not be enough to establish a diagnosis. Case presentation: we describe a peculiar case of severe hypercalcemia occurring in a 47-year-old woman with a previous history of post-surgical permanent hypoparathyroidism treated with calcitriol (0.5 µg bid) and calcium carbonate (1 g qd), which persisted after withdrawal of these drugs. During her follow-up, an ACTH-independent Cushing syndrome was diagnosed, leading to a unilateral right adrenalectomy. In the two months following surgery, she was admitted to the emergency ward on three occasions because of severe, persistent, idiopathic hypercalcemia. On each occasion, parathyroid hormone levels were confirmed to be undetectable, with low vitamin D levels. Common and rare causes of hypercalcemia were excluded, and the persistence of severely elevated calcium levels led to the empirical use of intravenous clodronate, achieving remission of both hypercalcemia and, unexpectedly, hypoparathyroidism. After 8 months, due to borderline-reduced calcium, calcitriol at 0.5 µg qd was restarted. After 18 months of follow-up, the patient is well and normocalcemic, with low-dose calcitriol. Notably, the patient had no acute adrenal insufficiency, distinguishing this case from other post-adrenalectomy hypercalcemia reports. Conclusions: the history of hypoparathyroidism makes this case even more unusual, and it encourages careful follow-up of hypoparathyroid patients with Cushing syndrome. Ongoing observation, as well as new research on the physiopathology of cortisol and calcium metabolism, are needed to clarify the pathogenesis of this case.
- Open Access
- 2 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (21) , 11779
Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management
Congenital Adrenal Hyperplasia (CAH) is a group of autosomal recessive endocrine disorders characterized by alteration in adrenal hormonal secretions. The most common form is caused by CYP21A2 mutations that result in 21-hydroxylase deficiency. Clinical features can vary, from salt-wasting forms, characterized by a lack of mineralocorticoid activity with a risk of perinatal-onset adrenal crises, to “simple-virilizing” forms with sufficient aldosterone secretion, up to milder “non-classical” forms, with a variable grade of hyperandrogenism but no severe hormonal deficiencies. During pregnancy, CAH 46,XX fetuses are exposed to elevated androgen levels, leading to a variable grade of virilization and potential central nervous system effects if untreated. These patients are usually (but not always) assigned female at birth, but some cases may be misdiagnosed and assigned male, potentially inducing fertility, gender identity, and sexual behavior issues in adulthood. In these patients, the benefits and risks of a late gender transition should be carefully evaluated. In this paper, we reviewed the literature concerning the most interesting peculiarities of these conditions.
- 2 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (21) , 11779
Open AccessSevere Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management
Congenital Adrenal Hyperplasia (CAH) is a group of autosomal recessive endocrine disorders characterized by alteration in adrenal hormonal secretions. The most common form is caused by CYP21A2 mutations that result in 21-hydroxylase deficiency. Clinical features can vary, from salt-wasting forms, characterized by a lack of mineralocorticoid activity with a risk of perinatal-onset adrenal crises, to “simple-virilizing” forms with sufficient aldosterone secretion, up to milder “non-classical” forms, with a variable grade of hyperandrogenism but no severe hormonal deficiencies. During pregnancy, CAH 46,XX fetuses are exposed to elevated androgen levels, leading to a variable grade of virilization and potential central nervous system effects if untreated. These patients are usually (but not always) assigned female at birth, but some cases may be misdiagnosed and assigned male, potentially inducing fertility, gender identity, and sexual behavior issues in adulthood. In these patients, the benefits and risks of a late gender transition should be carefully evaluated. In this paper, we reviewed the literature concerning the most interesting peculiarities of these conditions.
- 8 March 2023
- Published by Springer Nature in L'Endocrinologo
- Vol. 24 (2) , 174-176
Sindrome da inappropriata secrezione di TSH: adenoma ipofisario TSH secernente $vs$ sindrome da resistenza ormonale. Un’esperienza clinica- 8 March 2023
- Published by Springer Nature in L'Endocrinologo
- Vol. 24 (2) , 174-176
Sindrome da inappropriata secrezione di TSH: adenoma ipofisario TSH secernente $vs$ sindrome da resistenza ormonale. Un’esperienza clinica